QSevidence MedClaw connects evidence-based medical intelligence with OpenClaw multi-agent capabilities.

Multi-agent collaboration is moving quickly from developer tooling toward productized implementation. Since OpenClaw became open source, momentum around multi-agent systems has continued to grow. Volcano Engine launched the cloud SaaS version ArkClaw, Tencent introduced WorkBuddy for all-scenario AI agents, and agent collaboration patterns are spreading from technical communities into many industries. In healthcare, however, where accuracy and traceability are critical, the path for multi-agent implementation is still in an early stage of exploration.

On March 9, Qingsong Health officially launched QSevidence MedClaw, a medical AI collaboration system built through the deep integration of the evidence-based medical agent QSevidence and the OpenClaw multi-agent framework. After the upgrade, doctors can call OpenClaw's multi-agent collaboration capabilities directly inside the QSevidence platform without extra deployment or complex configuration. The system can complete a full closed loop from task decomposition, evidence retrieval and guideline comparison to conclusion generation and process archiving.

This means OpenClaw is no longer only a frontier framework in the developer community. Through a vertical product, it can be reached by front-line clinicians in an out-of-the-box way.

In the MedClaw collaboration body, QSevidence and OpenClaw perform different roles and operate together, forming a dual-engine architecture. QSevidence acts as the professional center, handling evidence retrieval, clinical guideline comparison and conclusion credibility grading to ensure that each step of the output has evidence and traceable sources. OpenClaw acts as the collaboration foundation, driving planning agents, content generation agents, process record agents and other agents to work together, integrating multi-step operations that doctors previously needed to connect manually into a complete workflow.

As a result, QSevidence is upgraded from a tool that answers questions into a system that processes problems. Evidence-based medicine no longer stops at retrieval; it becomes embedded in the doctor's decision-making chain.

In the early launch stage, QSevidence MedClaw will focus on three core scenarios. The first is evidence-based diagnosis and treatment decision support. After a doctor enters a clinical question, the collaboration body can automatically break the complex problem into subtasks, retrieve the latest literature and authoritative guidelines, and generate a structured evidence-based recommendation report through cross-comparison, while marking evidence levels and recommendation strength.

The second scenario is multi-guideline consistency comparison. For the same clinical question, the collaboration body can call multiple domestic and international guidelines in parallel, analyze them horizontally, present consensus and differences clearly, and help doctors form more comprehensive and cautious judgments in complex decision-making.

The third scenario is case discussion and research assistance. Around difficult case discussions and academic writing, the collaboration body can complete literature reviews, data organization and argument structuring, while recording the entire process for later review and audit.

As products such as ArkClaw move OpenClaw from deployable to ready-to-use, agents are entering a new stage of large-scale industry implementation. In healthcare, being usable is only the starting point; being trustworthy is the threshold.

The launch of QSevidence MedClaw represents a differentiated implementation path. It uses the traceability of evidence-based medicine as the foundation and redefines how multiple agents can collaborate in clinical environments. Going forward, Qingsong Health will further open medical knowledge access around the MedClaw collaboration body and explore deeper integration with hospital information systems and electronic medical record systems, pushing evidence-based collaboration from decision support toward workflow integration.

Original source: https://www.qingsonghealth.com/show-78.html